Receptors, Urokinase Plasminogen Activator
"Receptors, Urokinase Plasminogen Activator" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.
| Descriptor ID |
D055293
|
| MeSH Number(s) |
D12.776.395.550.448.813 D12.776.543.484.500.813 D12.776.543.550.418.813 D12.776.543.750.815
|
| Concept/Terms |
Receptors, Urokinase Plasminogen Activator- Receptors, Urokinase Plasminogen Activator
- CD87 Antigen
- Antigen, CD87
- Plasminogen Activator Receptor, Urokinase Type
- Plasminogen Activator, Urokinase Receptor
- Urokinase-Type Plasminogen Activator Receptors
- Urokinase Type Plasminogen Activator Receptors
- Receptor, Pro-Urokinase
- Pro-Urokinase Receptor
- Receptor, Pro Urokinase
- Receptor, Urokinase Plasminogen Activator
- U-PA Receptor
- Receptor, U-PA
- U PA Receptor
- Upar Receptor
- Receptor, Upar
- Urokinase Plasminogen Activator Receptors
- Antigens, CD87
- CD87 Antigens
- Plasminogen Activator, Urokinase Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Urokinase Plasminogen Activator".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Urokinase Plasminogen Activator".
This graph shows the total number of publications written about "Receptors, Urokinase Plasminogen Activator" by people in this website by year, and whether "Receptors, Urokinase Plasminogen Activator" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Urokinase Plasminogen Activator" by people in Profiles.
-
Diagnostic value of soluble urokinase-type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis. Cardiol J. 2024; 31(4):564-572.
-
A comprehensive review and meta-analysis of suPAR as a predictor of acute kidney injury. Ann Agric Environ Med. 2023 Jun 26; 30(2):364-368.
-
Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysis. Ann Agric Environ Med. 2023 Mar 31; 30(1):142-147.
-
Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
-
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab. 2017 05 01; 102(5):1642-1651.
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death. Circ Cardiovasc Qual Outcomes. 2017 03; 10(3).
-
Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease. Atherosclerosis. 2015 Mar; 239(1):55-60.
-
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc. 2014 10 23; 3(5):e001118.
-
Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis. 2013 Mar; 34(3):587-94.
-
The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res. 2013 Jan 01; 19(1):62-72.